ReferenceID 6217

Sinapic Acid Controls Inflammation by Suppressing NLRP3 Inflammasome Activation

Cells

A natural phenolic acid compound, sinapic acid (SA), is a cinnamic acid derivative that contains 3,5-dimethoxyl and 4-hydroxyl substitutions in the phenyl ring of cinnamic acid. SA is present in various orally edible nat

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
6217
Evidence Id
22807
Core Evidence Id
22807
Source Reference Id
5711
Herb2 Reference Id
HBREF006508
Subject Paper Key
HBIN044062_34571975
Pubmed Id
34571975
Doi
10.3390/cells10092327
Paper Title
Sinapic Acid Controls Inflammation by Suppressing NLRP3 Inflammasome Activation
Paper Abstract
A natural phenolic acid compound, sinapic acid (SA), is a cinnamic acid derivative that contains 3,5-dimethoxyl and 4-hydroxyl substitutions in the phenyl ring of cinnamic acid. SA is present in various orally edible natural herbs and cereals and is reported to have antioxidant, antitumor, anti-inflammatory, antibacterial, and neuroprotective activities. Although the anti-inflammatory function of SA has been reported, the effect of SA on the NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome has not been explored. In the present study, to elucidate the anti-inflammatory mechanism of SA, we examined whether SA modulates the NLRP3 inflammasome. We found that SA blocked caspase-1 activation and IL-1beta secretion by inhibiting NLRP3 inflammasome activation in bone marrow-derived macrophages (BMDMs). Apoptosis-associated speck-like protein containing CARD (ASC) pyroptosome formation was consistently blocked by SA treatment. SA specifically inhibited NLRP3 activation but not the NLRC4 or AIM2 inflammasomes. In addition, SA had no significant effect on the priming phase of the NLRP3 inflammasome, such as pro-IL-1beta and NLRP3 inflammasome expression levels. Moreover, we found that SA attenuated IL-1beta secretion in LPS-induced systemic inflammation in mice and reduced lethality from endotoxic shock. Our findings suggest that the natural compound SA has potential therapeutic value for the suppression of NLRP3 inflammasome-associated inflammatory diseases.
Journal
Cells
Publish Year
2021
Experiment Subject
mouse
Experiment Type
Cell Experiment
Phenotype Related
Endotoxic Shock; Nlrp3 Inflammasome-associated Inflammatory Diseases
Paper Title Cn
Paper Title En
Sinapic Acid Controls Inflammation by Suppressing NLRP3 Inflammasome Activation
Bilingual Status
semi_complete